公开(公告)号：US09434731B2

公开(公告)日：2016-09-06

申请号：US13905480

申请日：2013-05-30

申请人： Bayer Intellectual Property GmbH

发明人： Stephan Siegel ,  Andreas Wilmen ,  Susanne Röhrig ,  Niels Svenstrup ,  Mark Jean Gnoth ,  Stefan Heitmeier ,  Ulrich Rester ,  Adrian Tersteegen ,  Michael Gerisch

IPC分类号： A61K31/535 ,  C07D487/04 ,  C12N5/0789

CPC分类号： C07D487/04 ,  C12N5/0647

摘要： The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological disorders, preferably of leukopenias and neutropenias.

公开(公告)号：US08846934B2

公开(公告)日：2014-09-30

申请号：US13770270

申请日：2013-02-19

申请人： Bayer Intellectual Property GmbH

发明人： Swen Allerheiligen ,  Marcus Bauser ,  Dirk Heimbach ,  Stefan Heitmeier ,  Mark Gnoth ,  Christoph Gerdes ,  Georges Degenfeld ,  Susanne Röhrig ,  Ulrich Rester ,  Elke Dittrich-Wengenroth ,  Uwe Saatman ,  Adrian Tersteegen

IPC分类号： C07D413/00 ,  A61K31/44 ,  C07D413/14

CPC分类号： C07D413/14

摘要： The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.

摘要翻译： 本发明涉及新的取代的恶唑烷酮，其制备方法，其用于治疗和/或预防疾病及其用于制备用于治疗和/或预防疾病，特别是血栓栓塞性疾病的药物的用途。